Today: 23 January 2026
Subscribe
Browse Category

Pharmaceuticals News 29 December 2025 - 30 December 2025

BNAI stock doubles as Brand Engagement Network lands AI pharma deal, eyes recurring fees

BNAI stock doubles as Brand Engagement Network lands AI pharma deal, eyes recurring fees

NEW YORK, December 29, 2025, 23:20 ET — Market closed Brand Engagement Network, Inc shares more than doubled on Monday after the company disclosed a project agreement to develop a custom AI engagement tool tied to an established prescription drug for a top-10 global pharmaceutical client. The company said it expects $250,000 in fourth-quarter development revenue and anticipates monthly license…
30 December 2025
····
Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

NEW YORK, December 29, 2025, 22:14 ET Novo Nordisk said it is lowering prices of its top-selling obesity drug Wegovy in China, after local outlet Yicai reported that list prices for the two highest doses were cut by 48% in the southwestern provinces of Yunnan and Sichuan. The new monthly list prices were 987 yuan ($141) and 1,284 yuan, Yicai…
30 December 2025
···
Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

NEW YORK, December 29, 2025, 22:17 ET — Market closed Gilead Sciences (GILD.O) shares were last up 0.15% at $124.91 on Monday, as investors weighed an analyst note that argued new Medicaid drug-pricing rules would have a limited financial impact on the company’s HIV franchise. Investing The call matters now because drugmakers and investors are still parsing a Trump administration…
30 December 2025
····
Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus

Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus

NEW YORK, December 29, 2025, 22:14 ET — Market closed Amgen shares fell 1% on Monday, ending the session down $3.30 at $329.63. StockAnalysis The decline matters now because traders are heading into the final sessions of the year with U.S. indexes near record territory and liquidity thinner than usual. That backdrop can amplify moves in large-cap healthcare stocks even…
30 December 2025
····
Merck stock slips as 2025 winds down; MRK traders turn to Feb. 3 earnings next

Merck stock slips as 2025 winds down; MRK traders turn to Feb. 3 earnings next

NEW YORK, December 29, 2025, 20:35 ET — Market closed. Merck & Co (MRK) shares eased on Monday, last trading down about 0.1% at $106.62 after ranging between $106.44 and $107.56. Trading volume was about 8.1 million shares. The small move mattered mainly for timing. With the final three sessions of 2025 ahead, investors have been rebalancing portfolios in light…
30 December 2025
···
JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

NEW YORK, December 29, 2025, 20:26 ET — Market closed Johnson & Johnson (JNJ) shares were last down 0.02% at $207.56 on Monday after the healthcare conglomerate said it completed its $3.05 billion cash acquisition of cancer drug developer Halda Therapeutics. The stock traded between $207.31 and $209.46, and J&J said it will account for the deal as a business…
30 December 2025
····
Pfizer stock slips after hours: what traders are watching ahead of Feb. 3 results

Pfizer stock slips after hours: what traders are watching ahead of Feb. 3 results

NEW YORK, December 29, 2025, 19:33 ET — After-hours Pfizer Inc (NYSE: PFE) shares were down 0.3% at $25 in after-hours trading on Monday, after moving in a tight band during the regular session. The Health Care Select Sector SPDR Fund slipped and large-cap drugmakers traded mixed in late dealings. The move mattered mainly for timing. With just a handful…
30 December 2025
····
Eli Lilly stock today: LLY inches up as weight-loss pill pricing, insider filing keep spotlight on obesity drugs

Eli Lilly stock today: LLY inches up as weight-loss pill pricing, insider filing keep spotlight on obesity drugs

NEW YORK, December 29, 2025, 17:45 ET — After-hours Shares of Eli Lilly and Company (LLY) were up 0.2% at $1,078.73 in after-hours trading on Monday. The stock traded between $1,074.80 and $1,085.12 and about 1.64 million shares had changed hands. The modest move masked a bigger debate underway in the obesity-drug trade: pricing and access. Investors are watching whether…
29 December 2025
···
Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears

Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears

NEW YORK, December 29, 2025, 14:15 ET — Regular session Bristol Myers Squibb shares fell on Monday, with the drugmaker lagging a slightly weaker U.S. stock market in holiday-thinned trading. The stock was down 0.7% at $54.27 in afternoon trade. The move matters now because the final week of the year often brings abrupt swings on light volume, even when…
29 December 2025
····
Merck stock holds steady as year-end trading thins and Wall Street slips

Merck stock holds steady as year-end trading thins and Wall Street slips

NEW YORK, December 29, 2025, 12:47 ET — Regular session Merck & Co (MRK.N) shares were down 0.1% at $106.68 in midday trading on Monday, showing relative resilience as U.S. stocks drifted lower in thin year-end trade. The S&P 500-linked SPDR ETF (SPY) fell 0.6% and the Nasdaq-100 tracker (QQQ) slid 0.7%. The muted move matters because the market is…
29 December 2025
····
Pfizer filings spotlight big portfolio shifts as Live Oak slashes stake 92%

Pfizer filings spotlight big portfolio shifts as Live Oak slashes stake 92%

NEW YORK, December 29, 2025, 10:35 ET Live Oak Private Wealth LLC cut its stake in Pfizer (PFE.N) by 92.5% in the third quarter, selling 216,868 shares and ending the period with 17,627 shares, a regulatory filing showed. MarketBeat The disclosures matter because quarterly holdings reports are one of the few windows investors get into how money managers were positioned…
29 December 2025
····
Merck stock holds near 52-week high as year-end trading turns to Fed minutes

Merck stock holds near 52-week high as year-end trading turns to Fed minutes

NEW YORK, December 28, 2025, 21:37 ET — Market closed Merck & Co shares finished the last U.S. session up 0.3% at $106.78, closing just below a 52-week high after a quiet, post-Christmas session left the broader market marginally lower. Yahoo Finance The move matters for investors because late-December flows can push big, liquid drugmakers around even without fresh company…
29 December 2025
····
1 … 18 19 20 21 22 … 46

Stock Market Today

  • StubHub IPO lawsuit deadline nears as investors challenge cash flow disclosures
    January 22, 2026, 7:21 PM EST. Investors have until Jan. 23 to seek lead-plaintiff status in a lawsuit over StubHub's September IPO. The suit alleges the company and its executives, alongside underwriters like J.P. Morgan and Goldman Sachs, misled shareholders by not disclosing shifts in vendor payment timing that worsened free cash flow, a key financial metric measuring cash generated after operational costs. StubHub's free cash flow dropped to negative $4.6 million in the quarter ending Sept. 30, down from a positive $10.6 million a year earlier. The stock trades at around $15, well below its $23.50 IPO price. The case is in early stages, with StubHub citing timing effects as reasons for the cash flow changes. Legal teams are actively seeking investors to represent the class action in court.
Go toTop